Cargando…
Precision medicine: Clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’s diseases
The goal of precision medicine is to deliver optimally targeted and timed interventions tailored to an individual’s molecular drivers of disease. This concept has wide currency in cancer care and in some diseases caused by monogenetic mutations, such as cystic fibrosis, and recently has been endorse...
Autores principales: | Montine, Thomas J., Montine, Kathleen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419342/ https://www.ncbi.nlm.nih.gov/pubmed/25941321 http://dx.doi.org/10.1084/jem.20150656 |
Ejemplares similares
-
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
por: Hoekstra, Jake G, et al.
Publicado: (2011) -
Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson's disease and other diseases for which carriers are at increased risk
por: Lesniak, Robert K., et al.
Publicado: (2022) -
Single-cell peripheral immunoprofiling of Alzheimer’s and Parkinson’s diseases
por: Phongpreecha, Thanaphong, et al.
Publicado: (2020) -
Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice
por: Maezawa, Izumi, et al.
Publicado: (2006) -
CLARITY-BPA Program in Rats: Is It Translatable to Humans?
por: Hagobian, Todd
Publicado: (2019)